{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:18:12Z","timestamp":1783487892736,"version":"3.55.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Malignant adenomyoepithelioma (MAME) of the breast is a rare biphasic neoplasm with potential for local recurrence and distant metastasis. Preoperative diagnosis is often difficult because core needle biopsy (CNB) may undersample the biphasic and malignant features of the tumor. We report an 84-year-old woman, among the oldest described patients, who presented with a newly palpable left breast nodule. Breast ultrasonography demonstrated an indistinct hypoechoic subareolar lesion, and mammography showed a corresponding focal asymmetry without suspicious calcifications. CNB suggested invasive carcinoma of no special type with a triple-negative immunophenotype. The patient underwent breast-conserving surgery (BCS) with sentinel lymph node biopsy (SLNB) and an intraoperative radiotherapy (IORT) boost. Final pathology confirmed grade 3 malignant MAME measuring 16\u00a0mm, with perineural invasion and a Ki-67 proliferation index of 20%. Immunohistochemistry confirmed a biphasic epithelial and myoepithelial nature. Surgical margins were negative, and sentinel lymph nodes were uninvolved. The patient subsequently received adjuvant capecitabine chemotherapy and supplemental whole-breast irradiation (WBI), with only grade 1 hand\u2013foot syndrome, and showed no evidence of disease at 15 months of short-term follow-up. A pooled literature review showed substantial discordance between CNB and final pathology, supporting complete excision with comprehensive immunohistochemical evaluation. The principal contribution of this report is to highlight histologic-subtype discordance, in contrast to the malignancy-level discordance more commonly described, as a complementary diagnostic challenge in MAME. Across reported cases, negative-margin resection remained the cornerstone of management, lymph node involvement was uncommon, and late recurrence or distant metastasis could occur.<\/jats:p>","DOI":"10.3389\/fonc.2026.1844137","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:50:56Z","timestamp":1783486256000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Malignant breast adenomyoepithelioma with diagnostic discordance: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Jing-Jou","family":"Lo","sequence":"first","affiliation":[{"name":"Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University","place":["Kaohsiung, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Pei","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University","place":["Kaohsiung, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Feng","family":"Hou","sequence":"additional","affiliation":[{"name":"Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University","place":["Kaohsiung, Taiwan"]},{"name":"Kaohsiung Breast Cancer Prevention and Education Society","place":["Kaohsiung, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenobu","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University","place":["Kaohsiung, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1496057","article-title":"Malignant adenomyoepithelioma of the breast with axillary lymph node metastasis: A case report and review of the literature","volume":"15","author":"Wang","year":"2025","journal-title":"Front Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/his.14380","article-title":"Adenomyoepithelioma of the breast: A proposal for classification","volume":"79","author":"Rakha","year":"2021","journal-title":"Histopathology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.12390","article-title":"Malignant adenomyoepithelioma of the breast: A review","volume":"21","author":"Ahmadi","year":"2015","journal-title":"Breast J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-11-285","article-title":"Breast adenomyoepithelioma: A case report with Malignant proliferation of epithelial and myoepithelial elements","volume":"11","author":"Petrozza","year":"2013","journal-title":"World J Surg Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.13638","article-title":"Clinical presentation, national practice patterns, and outcomes of breast adenomyoepithelioma","volume":"26","author":"Haque","year":"2020","journal-title":"Breast J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2019.03.026","article-title":"Clinical characteristics and outcomes of benign, atypical, and Malignant breast adenomyoepithelioma: A single institution's experience","volume":"219","author":"Wiens","year":"2020","journal-title":"Am J Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2016.07.018","article-title":"Breast adenomyoepithelioma and adenomyoepithelioma with carcinoma (malignant adenomyoepithelioma) with associated breast Malignancies: A case series emphasizing histologic, radiologic, and clinical correlation","volume":"29","author":"Moritz","year":"2016","journal-title":"Breast"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000024461","article-title":"Malignant adenomyoepithelioma of the breast: A case report","volume":"100","author":"Zhang","year":"2021","journal-title":"Med (Baltimore)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1525050","article-title":"Malignant breast adenomyoepithelioma: Case report and literature review","volume":"11","author":"Ma","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12957-022-02593-3","article-title":"Clinicopathological characteristics and outcomes of Malignant adenomyoepithelioma of the breast: A single institution's experience","volume":"20","author":"Alqudaihi","year":"2022","journal-title":"World J Surg Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-9-148","article-title":"Malignant adenomyoepithelioma of the breast: Cases report and literature review","volume":"14","author":"Wang","year":"2022","journal-title":"Am J Transl Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i31.9549","article-title":"Malignant adenomyoepithelioma of the breast: Two case reports and review of the literature","volume":"9","author":"Zhai","year":"2021","journal-title":"World J Clin cases"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1055e","article-title":"Lessons from managing the breast Malignant adenomyoepithelioma and the discussion on treatment strategy","volume":"8","author":"Yuan","year":"2017","journal-title":"World J Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2021.02.002","article-title":"Adenomyoepithelioma of the breast: Case series and literature review","volume":"75","author":"Parikh","year":"2021","journal-title":"Clin Imaging"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s40792-020-00881-2","article-title":"Malignant adenomyoepithelioma of the breast","volume":"6","author":"Moro","year":"2020","journal-title":"Surg Case Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13019-016-0518-8","article-title":"Adenomyoepithelioma of the breast with late pulmonary metastases - Case report and review of the literature","volume":"11","author":"Korolczuk","year":"2016","journal-title":"J Cardiothorac Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2015.18.4.400","article-title":"Malignant adenomyoepithelioma of the breast and responsiveness to eribulin","volume":"18","author":"Lee","year":"2015","journal-title":"J Breast Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/305858","article-title":"Malignant adenomyoepithelioma of the breast with lymph node metastasis: A detailed immunohistochemical study","volume":"2012","author":"Awamleh","year":"2012","journal-title":"Case Rep Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/his.14799","article-title":"Pitfalls in breast pathology","volume":"82","author":"Quinn","year":"2023","journal-title":"Histopathology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2011-0404-RS","article-title":"Adenomyoepithelioma of the breast: A brief diagnostic review","volume":"137","author":"Yoon","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199209000-00005","article-title":"Adenomyoepithelioma of the breast. A spectrum of biologic behavior","volume":"16","author":"Loose","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2012.02982.x","article-title":"Malignant transformation of adenomyoepithelioma of the breast by a monophasic population: A report of two cases and review of literature","volume":"121","author":"Marian","year":"2013","journal-title":"Apmis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800961","article-title":"Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2\/Neu (basal-like breast carcinomas)","volume":"20","author":"Lerma","year":"2007","journal-title":"Mod Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2214\/ajr.180.3.1800799","article-title":"Adenomyoepithelioma of the breast: Spectrum of disease with associated imaging and pathology","volume":"180","author":"Howlett","year":"2003","journal-title":"AJR Am J Roentgenol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(24)00347-4","article-title":"Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial","volume":"25","author":"Williams","year":"2024","journal-title":"Lancet Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.5805","article-title":"Postoperative radiotherapy after breast-conserving surgery for early-stage breast cancer: A review","volume":"2","author":"Speers","year":"2016","journal-title":"JAMA Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/cancers18040699","article-title":"Long-term outcome of intraoperative radiotherapy for early-stage breast cancer","volume":"18","author":"Bratt","year":"2026","journal-title":"Cancers (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.3390\/cancers15164025","article-title":"Tumor bed boost radiotherapy in the conservative treatment of breast cancer: A review of intra-operative techniques and outcomes","volume":"15","author":"Sanz","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-13955-w","article-title":"Intraoperative radiotherapy as a tumour-bed boost combined with whole breast irradiation versus conventional radiotherapy in patients with early-stage breast cancer: A systematic review and meta-analysis","volume":"30","author":"He","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011987.pub2","article-title":"Tumour bed boost radiotherapy for women after breast-conserving surgery","volume":"11","author":"Kindts","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/s1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.03399","article-title":"Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: Asco guideline","volume":"39","author":"Korde","year":"2021","journal-title":"J Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(25)00545-5","article-title":"Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (Sysucc-001): Updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial","volume":"26","author":"Yuan","year":"2025","journal-title":"Lancet Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.23370","article-title":"Effect of capecitabine maintenance therapy using lower dosage and higher frequency vs observation on disease-free survival among patients with early-stage triple-negative breast cancer who had received standard treatment: The Sysucc-001 randomized clinical trial","volume":"325","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.5858\/2000-124-0632-maotbw","article-title":"Malignant adenomyoepithelioma of the breast with Malignant proliferation of epithelial and myoepithelial elements: A case report and review of the literature","volume":"124","author":"Ahmed","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199106000-00004","article-title":"Myoepithelial lesions of the breast: Myoepitheliosis, adenomyoepithelioma, and myoepithelial carcinoma","volume":"15","author":"Tavassoli","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/jscr\/rjae531","article-title":"Challenges in diagnosis and management of invasive ductal carcinoma in axillary ectopic breast tissue: A case study","volume":"2024","author":"Suliman","year":"2024","journal-title":"J Surg Case Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1844137\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:51:01Z","timestamp":1783486261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1844137\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":39,"alternative-id":["10.3389\/fonc.2026.1844137"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1844137","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"article-number":"1844137"}}